Found: 29
Select item for more details and to access through your institution.
Emulation of a randomized controlled trial in ulcerative colitis with US and French claims data: Infliximab with thiopurines compared to infliximab monotherapy.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2022, v. 31, n. 2, p. 167, doi. 10.1002/pds.5356
- By:
- Publication type:
- Article
Clinical activity is an independent risk factor of ischemic heart and cerebrovascular arterial disease in patients with inflammatory bowel disease.
- Published in:
- PLoS ONE, 2018, v. 13, n. 8, p. 1, doi. 10.1371/journal.pone.0201991
- By:
- Publication type:
- Article
Association Between Use of Thiopurines or Tumor Necrosis Factor Antagonists Alone or in Combination and Risk of Lymphoma in Patients With Inflammatory Bowel Disease.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Use of proton pump inhibitors in adults in France: a nationwide drug utilization study.
- Published in:
- European Journal of Clinical Pharmacology, 2020, v. 76, n. 3, p. 449, doi. 10.1007/s00228-019-02810-1
- By:
- Publication type:
- Article
Editorial: Pip pip to PIPs (post‐ inflammatory polyps) as a neoplasia risk factor in IBD? Authors' reply.
- Published in:
- 2023
- By:
- Publication type:
- Editorial
Letter: histologic disease activity and colorectal neoplasia risk—authors' reply.
- Published in:
- 2023
- By:
- Publication type:
- Letter to the Editor
Risk of colorectal neoplasia according to histologic disease activity in patients with inflammatory bowel disease and colonic post‐inflammatory polyps.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 57, n. 12, p. 1445, doi. 10.1111/apt.17495
- By:
- Publication type:
- Article
Impact of thiopurines and tumour necrosis factor antagonists on primary sclerosing cholangitis outcomes in patients with inflammatory bowel disease.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2022, v. 56, n. 5, p. 857, doi. 10.1111/apt.17123
- By:
- Publication type:
- Article
Tofacitinib as salvage therapy for 55 patients hospitalised with refractory severe ulcerative colitis: A GETAID cohort.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2021, v. 54, n. 3, p. 312, doi. 10.1111/apt.16463
- By:
- Publication type:
- Article
Long‐term outcome of patients with acute severe ulcerative colitis responding to intravenous steroids.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2020, v. 51, n. 11, p. 1096, doi. 10.1111/apt.15751
- By:
- Publication type:
- Article
The effectiveness of either ustekinumab or vedolizumab in 239 patients with Crohn's disease refractory to anti‐tumour necrosis factor.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2020, v. 51, n. 10, p. 948, doi. 10.1111/apt.15706
- By:
- Publication type:
- Article
Fecal microbiota transplantation to maintain remission in Crohn’s disease: a pilot randomized controlled study.
- Published in:
- Microbiome, 2020, v. 8, n. 1, p. 1, doi. 10.1186/s40168-020-0792-5
- By:
- Publication type:
- Article
Occurrence of inflammatory bowel disease in patients with chronic inflammatory skin diseases: a cohort study.
- Published in:
- British Journal of Dermatology, 2022, v. 187, n. 5, p. 692, doi. 10.1111/bjd.21704
- By:
- Publication type:
- Article
Pragmatic Trial Design to Compare Real-world Effectiveness of Different Treatments for Inflammatory Bowel Diseases: The PRACTICE-IBD European Consensus.
- Published in:
- Journal of Crohn's & Colitis, 2024, v. 18, n. 8, p. 1222, doi. 10.1093/ecco-jcc/jjae026
- By:
- Publication type:
- Article
Tofacitinib for Patients with Anti-TNF Refractory Ulcerative Proctitis: A Multicentre Cohort Study from the GETAID.
- Published in:
- Journal of Crohn's & Colitis, 2024, v. 18, n. 3, p. 424, doi. 10.1093/ecco-jcc/jjad169
- By:
- Publication type:
- Article
ECCO Guidelines on Inflammatory Bowel Disease and Malignancies.
- Published in:
- Journal of Crohn's & Colitis, 2023, v. 17, n. 6, p. 827, doi. 10.1093/ecco-jcc/jjac187
- By:
- Publication type:
- Article
Impact of Anti-tumour Necrosis Factor Agents on the Risk of Colorectal Cancer in Patients with Ulcerative Colitis: Nationwide French Cohort Study.
- Published in:
- Journal of Crohn's & Colitis, 2022, v. 16, n. 6, p. 893, doi. 10.1093/ecco-jcc/jjab184
- By:
- Publication type:
- Article
The IBD-disk Is a Reliable Tool to Assess the Daily-life Burden of Patients with Inflammatory Bowel Disease.
- Published in:
- Journal of Crohn's & Colitis, 2021, v. 15, n. 5, p. 766, doi. 10.1093/ecco-jcc/jjaa244
- By:
- Publication type:
- Article
Impact of Aphthous Colitis at Diagnosis on Crohn's Disease Outcomes.
- Published in:
- Journal of Crohn's & Colitis, 2020, v. 14, n. 3, p. 342, doi. 10.1093/ecco-jcc/jjz155
- By:
- Publication type:
- Article
Risk of Rectal Neoplasia after Colectomy and Ileorectal Anastomosis for Ulcerative Colitis.
- Published in:
- Journal of Crohn's & Colitis, 2017, v. 11, n. 8, p. 930, doi. 10.1093/ecco-jcc/jjx027
- By:
- Publication type:
- Article
Nouvelles stratégies thérapeutiques dans la colite aiguë sévère à l'ère des biothérapies et des anti-JAK.
- Published in:
- Hépato-Gastro & Oncologie Digestive, 2024, v. 31, n. 3, p. 333, doi. 10.1684/hpg.2024.2741
- By:
- Publication type:
- Article
Le patient MICI au centre de la prise en charge : importance de la tolérance dans le choix des traitements.
- Published in:
- Hépato-Gastro & Oncologie Digestive, 2022, v. 29, p. 17, doi. 10.1684/hpg.2021.2388
- By:
- Publication type:
- Article
Conséquences du statut Epstein-Barr Virus sur le traitement des maladies inflammatoires chroniques de l'intestin.
- Published in:
- Hépato-Gastro & Oncologie Digestive, 2020, v. 27, n. 2, p. 162, doi. 10.1684/hpg.2019.1929
- By:
- Publication type:
- Article
Facteurs prédictifs de réponse aux traitements lors d'une colite aiguë grave compliquant une rectocolite hémorragique.
- Published in:
- Hépato-Gastro & Oncologie Digestive, 2019, v. 26, n. 5, p. 469, doi. 10.1684/hpg.2019.1784
- By:
- Publication type:
- Article
Aortic Stiffening Is an Extraintestinal Manifestation of Inflammatory Bowel Disease: Review of the Literature and Expert Panel Statement.
- Published in:
- Angiology, 2020, v. 71, n. 8, p. 689, doi. 10.1177/0003319720918509
- By:
- Publication type:
- Article
Calibrating Real‐World Evidence Studies Against Randomized Trials: Treatment Effectiveness of Infliximab in Crohn's Disease.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 111, n. 1, p. 179, doi. 10.1002/cpt.2304
- By:
- Publication type:
- Article
Drug Repurposing in Crohn's Disease Using Danish Real-World Data.
- Published in:
- Pragmatic & Observational Research, 2024, v. 15, p. 17, doi. 10.2147/POR.S444569
- By:
- Publication type:
- Article
Prevalence of Self-Reported Venous Thromboembolism and Cardiovascular Risk Factors in Patients with Ulcerative Colitis: The GETAID FOCUS Study.
- Published in:
- Digestive Diseases & Sciences, 2022, v. 67, n. 9, p. 4525, doi. 10.1007/s10620-022-07445-4
- By:
- Publication type:
- Article
Impact on Life Expectancy of Withdrawing Thiopurines in Patients with Crohn’s Disease in Sustained Clinical Remission: A Lifetime Risk-Benefit Analysis.
- Published in:
- PLoS ONE, 2016, v. 11, n. 6, p. 1, doi. 10.1371/journal.pone.0157191
- By:
- Publication type:
- Article